Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia. - Test2 - elhamkhani - TriplyDB

Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia.

Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q37618885

about

Impairments that influence physical function among survivors of childhood cancer Imatinib-based therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemia: A case report and literature review Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia Treatment of Osteonecrosis in Children and Adolescents With Acute Lymphoblastic Leukemia.Osteonecrosis following treatment for childhood acute lymphoblastic leukaemia: The Southampton Children's Hospital experience.Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.Outcome of childhood leukaemia survivors and necrosis of the femoral head treated with autologous mesenchymal stem cells.Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia.Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP)

P2860

Q35082766-6B3EC73B-BEA7-4A57-9F6F-C7F725C06FA1 Q36085424-4C71B240-36F0-4561-BD10-BA809E787A3B Q36337592-7CE17865-C6F7-4491-8B51-C7C33D6CEAD1 Q36743109-19D177BD-55EE-40A9-8BBF-D6D54DC0BB12 Q47136686-64E04087-D3DC-4CA0-A9FF-8CC6CFE95A4E Q47706549-5EDC54E1-AB9C-492A-841A-4F4E535760F4 Q48357079-D74E7A7E-E164-42B3-817D-1A4ACFED6613 Q51671049-C077D93A-2713-459E-A347-D18EBAC8A7A9 Q59136673-606D58AE-AFB2-409B-83BE-964D9EE5377E

P2860

Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q37618885

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Management and treatment of os ...... acute lymphoblastic leukemia.

@en

Management and treatment of os ...... acute lymphoblastic leukemia.

@nl

type

label

Management and treatment of os ...... acute lymphoblastic leukemia.

@en

Management and treatment of os ...... acute lymphoblastic leukemia.

@nl

prefLabel

Management and treatment of os ...... acute lymphoblastic leukemia.

@en

Management and treatment of os ...... acute lymphoblastic leukemia.

@nl

P1433

Q37618885-F8F2F666-E1AC-44D0-9741-8910723397BB

P1476

Q37618885-5409019B-49F7-4934-BB3E-1B5F8C278BF9

P2093

Q37618885-73BA600D-AE06-4E45-A55D-9ECD54704B17

Q37618885-BE86DC42-9BA1-4A56-933F-305B10228AF5

Q37618885-F3535792-3D1C-4D3A-A27E-DF0AF8080C2B

P2860

Q37618885-01BAE4FC-5188-43B4-9DD3-C256743BD501

Q37618885-07D3E8A6-895E-482A-8755-3A484A34659C

Q37618885-0C33FBEB-2348-4FAD-B9E7-217C37D1B2D3

Q37618885-0E76ADE0-0E71-4D07-AF5E-7B273565EAE9

Q37618885-115AA418-A0BD-433F-A693-9F7316A291FA

Q37618885-1851D149-31DD-4BBE-A233-8705D53B0403

Q37618885-1FAD22AD-13A9-4826-9CD5-D87B5FEB61FF

Q37618885-25E25084-7F95-4280-9C0A-ACE06D39E8BA

Q37618885-3EE1F5C7-3A29-47DB-B9B9-C22DC6E329AC

Q37618885-3FFDBB77-8731-41AC-A3E4-9D6A90F3485C

P304

Q37618885-C840B004-DBE5-4A53-A828-512194065F1F

P31

Q37618885-70e88563-2eee-4c90-9a12-23ed22e6a553

Q37618885-E7348CAF-4AE3-47D4-AD5B-2D4368A89FE5

P356

Q37618885-3D8B57C0-DAEA-4F41-9BB3-8D7917CDE175

P433

Q37618885-987B093A-8B4B-455C-8CFF-742F6E01297F

P478

Q37618885-460BF98E-077B-45C2-9362-7AC4A584B46C

P50

Q37618885-E1CED729-89CC-490A-82DA-8502FB683787

Q37618885-F1E09C94-2A95-4B94-8576-37EEC007585F

P577

Q37618885-98FC27F3-C330-4EDA-A294-AAAB6C7F3866

P5875

Q37618885-2E9FBEF2-DE0D-46C0-AC31-78516C35CF93

P698

Q37618885-25D1703E-4075-4487-B937-E202C6CADBDB

P921

Q37618885-791C21E8-B4F5-4F9D-8526-39C6FB7EF89E

Q37618885-BAA65001-9020-449A-B06F-26585204F6A4

P932

Q37618885-E4C80F25-2DFE-4ADE-844D-84E85167A51F

P356

HAEMATOL.2013.095562

P1433

P1476

Management and treatment of os ...... acute lymphoblastic leukemia.

@en

P2093

Ernst-Jan D Wind

http://www.w3.org/2001/XMLSchema#string

J H J M Gert Bessems

http://www.w3.org/2001/XMLSchema#string

Mariël L Te Winkel

http://www.w3.org/2001/XMLSchema#string

P2860

Fresh osteochondral allografting for steroid-associated osteonecrosis of the femoral condyles.

Sequelae of Perthes disease: treatment with surgical hip dislocation and relative femoral neck lengthening.

The need for total hip arthroplasty in Perthes disease: a long-term study.

Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.

Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease.

The skeletal remains: porosis and necrosis of bone in the marrow transplantation setting.

Comparison between innominate osteotomy and arthrodistraction as a primary treatment for Legg-Calvé-Perthes disease: a prospective controlled trial.

Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

Does valgus femoral osteotomy improve femoral head roundness in severe Legg-Calvé-Perthes disease?

P304

430-436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2013.095562

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Marry M van den Heuvel-Eibrink

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260562580

http://www.w3.org/2001/XMLSchema#string

P698

24598854

http://www.w3.org/2001/XMLSchema#string

P921

P932

3943305

http://www.w3.org/2001/XMLSchema#string